Home › NDC Lookup › RxCUI directory › RxCUI 1737744

500 ML lidocaine hydrochloride 4 MG/ML Injection — RxCUI 1737744

Name: 500 ML lidocaine hydrochloride 4 MG/ML Injection (RxCUI 1737744)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1737744 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1737744

Official name500 ML lidocaine hydrochloride 4 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known aslidocaine HCl 2 GM per 500 ML Injection; lidocaine HCl 0.4 % in 500 ML Injection; lidocaine HCl 0.4 % per 500 ML Injection

FDA products mapped4

Package NDCs mapped5

Reported Medicaid activity (SDUD)1,606 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
What is this patch actually for — why did my doctor prescribe it?
You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
How long do I wear the patch, and can I wear more than one?

📖 Read our full Lidocaine Transdermal Patch guide →

🕸️ Concept Web — How 500 ML lidocaine hydrochloride 4 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 500 ML lidocaine hydrochloride 4 MG/ML Injection RxCUI 1737744 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Lidocaine 6387 IN
- Lidocaine hydrochloride 142440 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Lidocaine Injection 1737342 SCDF
- Lidocaine hydrochloride Injection 2646960 SCDFP
- Lidocaine Injectable Product 1164658 SCDG
- Lidocaine hydrochloride Injectable Product 2663499 SCDGP
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Lidocaine hydrochloride 4 MG/ML 1010859 SCDC

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Lidocaine hydrochloride 4 MG/ML SCDC · 1010859
Lidocaine Injection SCDF · 1737342
Lidocaine hydrochloride Injection SCDFP · 2646960
Lidocaine Injectable Product SCDG · 1164658
Lidocaine hydrochloride Injectable Product SCDGP · 2663499

📦 FDA Products & Package NDCs

4 products · 5 package NDCs

5 package NDCs map to RxCUI 1737744 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00264-9594-10	24 CONTAINER in 1 CASE (0264-9594-10) / 500 mL in 1 CONTAIN...	Lidocaine Hydrochloride and Dextrose	B. Braun Medical Inc.	1992-04-08
00264-9594-20	24 CONTAINER in 1 CASE (0264-9594-20) / 250 mL in 1 CONTAIN...	Lidocaine Hydrochloride and Dextrose	B. Braun Medical Inc.	1992-04-08
00264-9598-20	24 CONTAINER in 1 CASE (0264-9598-20) / 250 mL in 1 CONTAIN...	Lidocaine Hydrochloride and Dextrose	B. Braun Medical Inc.	1992-04-08
00338-0409-03	18 BAG in 1 CARTON (0338-0409-03) / 500 mL in 1 BAG	Lidocaine Hydrochloride and Dextrose	Baxter Healthcare Corporation	1981-04-22
00338-0411-02	24 BAG in 1 CARTON (0338-0411-02) / 250 mL in 1 BAG	Lidocaine Hydrochloride and Dextrose	Baxter Healthcare Corporation	1981-04-22

Observed labelers: B. Braun Medical Inc. (3) · Baxter Healthcare Corporation (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2002	Inj, lidocaine in d5w, 1 mg	5	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.